These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3447702)

  • 21. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
    Kayali A
    Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
    [No Abstract]   [Full Text] [Related]  

  • 22. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
    Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
    Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term therapeutic efficacy with once-daily isosorbide-5-mononitrate (Imdur).
    Kendall MJ
    J Clin Pharm Ther; 1990 Jun; 15(3):169-85. PubMed ID: 2195051
    [No Abstract]   [Full Text] [Related]  

  • 24. [Previous history and principles of the development of isosorbide-5-mononitrate (IS-5-MN)].
    Schaumann W
    Med Welt; 1981 Apr; 32(14A):479-80. PubMed ID: 7242305
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ergometric evaluation of the efficacy of a delayed-action nitroderivative].
    Vajola SF; Boccardi L; Cacciatore G; Minardi G; Pozzar F; Schiavo B
    Boll Soc Ital Cardiol; 1981; 26(11):1417-20. PubMed ID: 7349184
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mononitrates in long-term prophylaxis of angina pectoris: results of the first isosorbid-5-mononitrate symposium in Mannheim].
    Fortschr Med; 1981 Feb; 99(6):200-2. PubMed ID: 7024071
    [No Abstract]   [Full Text] [Related]  

  • 27. Conventional and slow release formulations of nifedipine and verapamil are more effective than slow release isosorbide dinitrate (ISDN) in preventing episodes of angina at rest.
    Schneeweiss A
    Eur Heart J; 1987 Apr; 8(4):435-6. PubMed ID: 3609039
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of sustained-action isosorbide dinitrate on exercise-induced myocardial ischemia.
    Brunner D; Meshulam N; Zerieker F
    Chest; 1974 Sep; 66(3):282-7. PubMed ID: 4607776
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
    Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
    Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
    [No Abstract]   [Full Text] [Related]  

  • 30. [The prophylactic effect of a combination of pindolol and isosorbide dinitrate on angina pectoris induced by arterial stimulation (author's transl)].
    Gavrilescu S; Pantzer M
    Schweiz Rundsch Med Prax; 1977 Aug; 66(35):1121-6. PubMed ID: 335384
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of oral administration of subcontinuous doses of delayed-action isosorbide-5-mononitrate. Absence of tolerance].
    Lai C; Onnis E; Orani E; Soro A; Pirisi R; Cherchi A
    Cardiologia; 1988 Nov; 33(11):1069-74. PubMed ID: 3076514
    [No Abstract]   [Full Text] [Related]  

  • 32. [Isosorbide-5-mononitrate. A metabolite of isosorbide dinitrate].
    Aldershvile J; Abildgaard U
    Ugeskr Laeger; 1985 Jun; 147(24):1948-9. PubMed ID: 4024344
    [No Abstract]   [Full Text] [Related]  

  • 33. The rationale for nitrates in angina pectoris.
    Held P; Olsson G
    Can J Cardiol; 1995 Apr; 11 Suppl B():11B-13B. PubMed ID: 7728648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of time and dosage of isosorbide mononitrate on objective and subjective parameters in angina pectoris].
    Herrmann H; Kuhl A; Maier-Lenz H
    Arzneimittelforschung; 1988 May; 38(5):694-8. PubMed ID: 3415710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease].
    Sizova ZM; Kozlova NV; Zakharova VL; Shameeva ES
    Kardiologiia; 2015; 55(2):10-5. PubMed ID: 26164982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
    Romeo F; Barillà F; Pelliccia F; Ferraironi A; Ciolli A; Pannarale G; Vicchio D; Valente A
    Cardiologia; 1989 Jul; 34(7):643-50. PubMed ID: 2676173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and length of action of a slow-release formulation of isosorbide-5-mononitrate in stable effort angina].
    Lagioia R; Scrutinio D; Mangini SG; Mastropasqua F; Caporale R; Mancini G; Loliva F; Rizzon P
    Cardiologia; 1989 Feb; 34(2):155-60. PubMed ID: 2660992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of modified release isosorbide mononitrate affected by incorrect use.
    Hider JD; Shehab Z; Courteney-Harris R
    BMJ; 2000 Feb; 320(7233):483. PubMed ID: 10678861
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of antianginal efficacy of sustained release isosorbide dinitrate with short-acting isosorbide dinitrate.
    Joseph G
    Indian Heart J; 1991; 43(6):477. PubMed ID: 1823901
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of a clinical multicenter study with Mono Mack 20 mg/40 mg].
    Schmidt G; Keller H; Jobst E
    Med Welt; 1983 Nov; 34(46):1322-4. PubMed ID: 6645932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.